Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.

PubWeight™: 8.51‹?› | Rank: Top 0.1%

🔗 View Article (PMID 12473543)

Published in Circulation on December 10, 2002

Authors

Alain Cribier1, Helene Eltchaninoff, Assaf Bash, Nicolas Borenstein, Christophe Tron, Fabrice Bauer, Genevieve Derumeaux, Frederic Anselme, François Laborde, Martin B Leon

Author Affiliations

1: Department of Cardiology, Charles Nicolle Hospital, University of Rouen, Rouen, France. Alain.Cribier@chu-rouen.fr

Associated clinical trials:

Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI (EASY TAVI) | NCT02781896

German Aortic Valve Registry (GARY) | NCT01165827

Outcomes of Transcatheter Aortic Valve Implantation in Management of Severe Symptomatic Aortic Stenosis (TAVI) | NCT03633383

Comparison of Transaxillary and Transfemoral Fully-percutaneous Approaches for Transcatheter Aortic Valve Implantation (TRANSAX) | NCT04274751

Articles citing this

(truncated to the top 100)

Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 3.56

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11

Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothorac Surg (2013) 1.87

One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J (2010) 1.63

Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly. Clin Res Cardiol (2008) 1.62

Single center TAVR experience with a focus on the prevention and management of catastrophic complications. Catheter Cardiovasc Interv (2014) 1.43

Cardiac surgery: a century of progress. Tex Heart Inst J (2011) 1.40

Fluid mechanics of artificial heart valves. Clin Exp Pharmacol Physiol (2009) 1.40

The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J (2013) 1.39

Patients with small left ventricular size undergoing balloon aortic valvuloplasty have worse intraprocedural outcomes. Catheter Cardiovasc Interv (2012) 1.39

Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature. Clin Res Cardiol (2010) 1.23

Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol (2011) 1.22

Aortic valves stenosis and regurgitation: assessment with dual source computed tomography. Int J Cardiovasc Imaging (2009) 1.13

Dual source multidetector CT-angiography before Transcatheter Aortic Valve Implantation (TAVI) using a high-pitch spiral acquisition mode. Eur Radiol (2011) 1.09

Transcatheter aortic valve implantation: Current status and future perspectives. World J Cardiol (2011) 1.06

Futility, benefit, and transcatheter aortic valve replacement. JACC Cardiovasc Interv (2014) 1.04

Real-time MRI guided atrial septal puncture and balloon septostomy in swine. Catheter Cardiovasc Interv (2006) 1.02

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. Open Heart (2014) 1.02

In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol (2016) 1.00

Indication for percutaneous aortic valve implantation. Arch Med Sci (2010) 1.00

Pseudoaneurysm of the left ventricle following apical approach TAVI. J Cardiovasc Magn Reson (2011) 0.97

Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz (2009) 0.93

Transcatheter versus surgical aortic valve replacement in intermediate risk patients: a meta-analysis. Cardiovasc Diagn Ther (2016) 0.92

Closed bore XMR (CBXMR) systems for aortic valve replacement: active magnetic shielding of x-ray tubes. Med Phys (2009) 0.92

Polymeric trileaflet prosthetic heart valves: evolution and path to clinical reality. Expert Rev Med Devices (2012) 0.91

EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology. J Cardiovasc Transl Res (2011) 0.91

Transcatheter aortic valve replacement in elderly patients. J Geriatr Cardiol (2012) 0.90

Percutaneous transvenous Melody valve-in-ring procedure for mitral valve replacement. J Am Coll Cardiol (2011) 0.89

The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study. J Cardiothorac Surg (2009) 0.89

The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase. Interact Cardiovasc Thorac Surg (2013) 0.89

Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology. Clin Res Cardiol (2009) 0.89

Remodelling of the aortic root in severe tricuspid aortic stenosis: implications for transcatheter aortic valve implantation. Eur Radiol (2009) 0.88

New percutaneous treatments for valve disease. Heart (2007) 0.88

Closed-bore XMR (CBXMR) systems for aortic valve replacement: x-ray tube imaging performance. Med Phys (2009) 0.88

Transcatheter aortic valve replacement: design, clinical application, and future challenges. Yale J Biol Med (2012) 0.88

Technique of transcatheter aortic valve implantation with the Edwards-Sapien heart valve using the transfemoral approach. Herz (2009) 0.87

Multimodality imaging in interventional cardiology. Nat Rev Cardiol (2012) 0.87

Temporary support with Tandemheart pVAD during percutaneous aortic valve replacement in an animal model: rationale and methodology. Tex Heart Inst J (2005) 0.87

Society of Thoracic Surgeons Risk Score predicts hospital charges and resource use after aortic valve replacement. J Thorac Cardiovasc Surg (2011) 0.87

Imaging in Transcatheter Aortic Valve Replacement (TAVR): role of the radiologist. Insights Imaging (2014) 0.87

Acute regional improvement of myocardial function after interventional transfemoral aortic valve replacement in aortic stenosis: a speckle tracking echocardiography study. Cardiovasc Ultrasound (2012) 0.86

Implantation of the CoreValve self-expanding valve prosthesis via a subclavian artery approach: a case report. Clin Res Cardiol (2009) 0.86

Simulations of transcatheter aortic valve implantation: implications for aortic root rupture. Biomech Model Mechanobiol (2014) 0.86

First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex Heart Inst J (2005) 0.86

Self-Expanding Stent and Delivery System for Aortic Valve Replacement. J Med Device (2012) 0.85

Vascular access in transcatheter aortic valve implantation. Int J Cardiovasc Imaging (2011) 0.85

Single-source dual-energy CT angiography with reduced iodine load in patients referred for aortoiliofemoral evaluation before transcatheter aortic valve implantation: impact on image quality and radiation dose. Eur Radiol (2014) 0.85

There are two sides to everything: two case reports on sequelae of rescue interventions to treat complications of transcatheter aortic valve implantation of the Medtronic CoreValve prosthesis. Clin Res Cardiol (2010) 0.84

Worldwide TAVI registries: what have we learned? Clin Res Cardiol (2014) 0.84

New conduction abnormalities after TAVI--frequency and causes. Nat Rev Cardiol (2012) 0.83

Percutaneous ventricular assist during aortic valvuloplasty: potential application to the deployment of aortic stent-valves. Tex Heart Inst J (2007) 0.83

Transcatheter valve repair/implantation. Int J Cardiovasc Imaging (2011) 0.83

Closed bore XMR (CBXMR) systems for aortic valve replacement: investigation of rotating-anode x-ray tube heat loadability. Med Phys (2008) 0.83

In vitro hydrodynamic evaluation of a biovalve with stent (tubular leaflet type) for transcatheter pulmonary valve implantation. J Artif Organs (2015) 0.82

The impact of transcatheter aortic valve implantation on patients' profiles and outcomes of aortic valve surgery programmes: a multi-institutional appraisal. Interact Cardiovasc Thorac Surg (2013) 0.82

The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial. Trials (2014) 0.81

CT angiography after 20 years: a transformation in cardiovascular disease characterization continues to advance. Radiology (2014) 0.81

Transcatheter aortic valve implantation (TAVI): the hype and the hope. Tex Heart Inst J (2013) 0.81

Aortic regurgitation after transcatheter aortic valve implantation: mechanisms and implications. Cardiovasc Diagn Ther (2013) 0.81

Imaging for approach selection of TAVI: assessment of the aorto-iliac tract diameter by computed tomography-angiography versus projection angiography. Int J Cardiovasc Imaging (2013) 0.80

Balloon expandable transcatheter aortic valve implantation with or without pre-dilation of the aortic valve - rationale and design of a multicenter registry (EASE-IT). BMC Cardiovasc Disord (2014) 0.80

Clinical trial experience with transcatheter aortic valve insertion. Int J Cardiovasc Imaging (2011) 0.80

Infective complications after transcatheter aortic valve implantation: results from a single centre. Neth Heart J (2012) 0.80

The versatility of transapical access: Will it lead to a completely new approach to valvular therapy? Ann Cardiothorac Surg (2012) 0.80

Transcatheter aortic valve implantation with balloonexpandable valve: early experience from China. Braz J Cardiovasc Surg (2015) 0.80

Heart Valve Replacements with Regenerative Capacity. Transfus Med Hemother (2016) 0.80

Durability of prostheses for transcatheter aortic valve implantation. Nat Rev Cardiol (2016) 0.80

Anesthetic considerations of percutaneous transcatheter aortic valve implantation: first attempt in Korea -A report of 2 cases-. Korean J Anesthesiol (2011) 0.80

Role of transcatheter aortic valve implantation (TAVI) versus conventional aortic valve replacement in the treatment of aortic valve disease. Methodist Debakey Cardiovasc J (2012) 0.80

Valve implantation on the beating heart: catheter-assisted surgery for aortic stenosis. Dtsch Arztebl Int (2009) 0.80

Parallel improvement of left ventricular geometry and filling pressure after transcatheter aortic valve implantation in high risk aortic stenosis: comparison with major prosthetic surgery by standard echo Doppler evaluation. Cardiovasc Ultrasound (2013) 0.80

Transcatheter aortic valve implantation. Surg Today (2014) 0.80

Blood flow characteristics in the ascending aorta after TAVI compared to surgical aortic valve replacement. Int J Cardiovasc Imaging (2015) 0.80

Transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis of randomised and non-randomised trials. Open Heart (2014) 0.79

Update of transcatheter valve treatment. J Zhejiang Univ Sci B (2013) 0.79

Progress in ring array transducers for real-time 3D ultrasound guidance of cardiac interventional devices. Ultrason Imaging (2011) 0.79

Thrombogenic potential of transcatheter aortic valve implantation with trivial paravalvular leakage. Ann Transl Med (2014) 0.79

Comparison of transcatheter aortic valve and surgical bioprosthetic valve durability: A fatigue simulation study. J Biomech (2015) 0.79

Unexpected and fatal hemodynamic collapse during transapical transcatheter aortic valve implantation -A case report-. Korean J Anesthesiol (2013) 0.79

Next-generation transcatheter heart valves: current trials in Europe and the USA. Methodist Debakey Cardiovasc J (2012) 0.79

Mechanisms and management of TAVR-related complications. Nat Rev Cardiol (2013) 0.79

Comparison of aortic annulus diameter measurement between multi-detector computed tomography and echocardiography: a meta-analysis. PLoS One (2013) 0.79

Periprocedural considerations of transcatheter aortic valve implantation for anesthesiologists. J Cardiovasc Thorac Res (2016) 0.78

The Nordic aortic valve intervention (NOTION) trial comparing transcatheter versus surgical valve implantation: study protocol for a randomised controlled trial. Trials (2013) 0.78

Transarterial aortic valve replacement with a self expanding stent in pigs. Heart (2004) 0.78

Surgical experience of ascending aorta and aortic valve replacement in patient with calcified aorta. Korean J Thorac Cardiovasc Surg (2012) 0.78

Which way in? The necessity of multiple approaches to transcatheter valve therapy. Curr Cardiol Rev (2013) 0.78

Emerging approaches of transcatheter valve repair/insertion. Cardiol Res Pract (2010) 0.78

Transapical Implantation of a 2nd-Generation JenaValve Device in Patient with Extremely High Surgical Risk. Case Rep Cardiol (2015) 0.78

Multi-detector computed tomography is equivalent to trans-oesophageal echocardiography for the assessment of the aortic annulus before transcatheter aortic valve implantation. Eur Radiol (2012) 0.77

The change in mitral regurgitation severity after trans-catheter aortic valve implantation. J Saudi Heart Assoc (2014) 0.77

Interventional imaging: the role of echocardiography. Methodist Debakey Cardiovasc J (2015) 0.77

Clinical efficacy of transcatheter aortic valve replacement for severe aortic stenosis in high-risk patients: the PREVAIL JAPAN trial. Surg Today (2014) 0.77

Colombian experience with transcatheter aortic valve implantation of medtronic CoreValve. Tex Heart Inst J (2012) 0.77

Role of Echocardiography Before Transcatheter Aortic Valve Implantation (TAVI). Curr Cardiol Rep (2016) 0.77

Minimally invasive aortic valve replacement: the "Miami Method". Ann Cardiothorac Surg (2015) 0.77

CT predictors of post-procedural aortic regurgitation in patients referred for transcatheter aortic valve implantation: an analysis of 105 patients. Int J Cardiovasc Imaging (2013) 0.77

TAVI: New trials and registries offer further welcome evidence - U.S. CoreValve, CHOICE, and GARY. Glob Cardiol Sci Pract (2014) 0.77

Quantification of biomechanical interaction of transcatheter aortic valve stent deployed in porcine and ovine hearts. Ann Biomed Eng (2012) 0.77

[Transcatheter-based aortic valve implantation. Present and future technologies]. Herz (2009) 0.77

Articles by these authors

Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70

A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29

Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26

Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77

Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med (2015) 6.28

Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27

Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med (2015) 5.90

A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol (2004) 5.67

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med (2007) 5.37

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47

Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol (2012) 4.29

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet (2012) 4.02

Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol (2004) 3.67

Long-term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv (2011) 3.38

Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29

Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr (2011) 3.07

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA (2004) 2.89

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78

Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation (2012) 2.71

Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol (2012) 2.56

Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol (2008) 2.54

Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation (2002) 2.53

Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol (2005) 2.42

Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr (2008) 2.42

Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation (2009) 2.40

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation (2004) 2.35

A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. JACC Cardiovasc Interv (2009) 2.30

Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation (2004) 2.28

Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol (2004) 2.20

Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol (2006) 2.16

Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol (2006) 2.12

The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention. J Invasive Cardiol (2010) 2.10

Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ (2008) 2.09

The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv (2012) 2.08

Cause of death with bare metal and sirolimus-eluting stents. Eur Heart J (2006) 2.04

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99

Surgical aortic valve replacement after percutaneous aortic valve implantation: what have we learned? J Thorac Cardiovasc Surg (2008) 1.99

Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol (2002) 1.95

The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol (2010) 1.90

Medical device development: from prototype to regulatory approval. Circulation (2004) 1.90

Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation (2009) 1.88

Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation (2004) 1.87

Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol (2004) 1.84

Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation (2004) 1.83

Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv (2010) 1.81

Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol (2012) 1.80

Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation (2011) 1.79

Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol (2013) 1.79

Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol (2003) 1.77

Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv (2011) 1.75

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74

Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol (2005) 1.73

The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention (2013) 1.72

Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. J Am Coll Cardiol (2005) 1.72

Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation (2004) 1.72

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72

Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv (2008) 1.70

Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation (2011) 1.69

Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol (2004) 1.68

Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol (2012) 1.67

Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol (2012) 1.66

In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry. Eur Heart J (2008) 1.65

Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era. Am J Cardiol (2011) 1.63

Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol (2003) 1.62

Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol (2013) 1.62

Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol (2004) 1.61

Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol (2012) 1.61

Evaluation of left ventricular diastolic function with cardiac MR imaging. Radiographics (2011) 1.61

Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation (2005) 1.60

Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv (2012) 1.59

Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft. Am J Cardiol (2006) 1.59

Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol (2004) 1.57

Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int (2005) 1.57

Drug-eluting stents: costs versus clinical benefit. Circulation (2003) 1.57

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol (2006) 1.56

B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur Heart J (2009) 1.56

Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation (2006) 1.56

Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry). Am J Cardiol (2009) 1.56

Dual catheter technique for the treatment of severe coronary artery perforations. Catheter Cardiovasc Interv (2010) 1.55

Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation (2002) 1.55

Impact of the Advisa MRI pacing system on the diagnostic quality of cardiac MR images and contraction patterns of cardiac muscle during scans: Advisa MRI randomized clinical multicenter study results. Heart Rhythm (2013) 1.54

Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation (2004) 1.54

Safety and performance of targeted renal therapy: the Be-RITe! Registry. J Endovasc Ther (2009) 1.54

Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. Lancet (2013) 1.53

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial. EuroIntervention (2013) 1.53

Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol (2004) 1.53

Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv (2009) 1.53

A new dual-chamber pacing mode to minimize ventricular pacing. Pacing Clin Electrophysiol (2005) 1.52

Sutureless perceval aortic valve replacement: results of two European centers. Ann Thorac Surg (2012) 1.51